| P2093 | author name string | Thase ME | |
| | Salloum IM | |
| P2860 | cites work | Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 |
| | Drugs of abuse and the brain | Q33603922 |
| | Bipolarity in children | Q33768230 |
| | Transduction of psychosocial stress into the neurobiology of recurrent affective disorder | Q33969745 |
| | Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity | Q34057638 |
| | The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence | Q34194511 |
| | Should protracted withdrawal from drugs be included in DSM-IV? | Q34334862 |
| | Molecular and cellular basis of addiction | Q34440561 |
| | Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndromes | Q35899188 |
| | Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal | Q37615761 |
| | Oral ethanol self-administration: a behavioral pharmacological approach to CNS control mechanisms | Q37919047 |
| | Medication compliance among patients with bipolar disorder and substance use disorder. | Q38551953 |
| | Comorbidity of substance abuse and other psychiatric disorders in adolescents | Q38676553 |
| | Alcohol Intoxication and Withdrawal | Q39084726 |
| | Neuroendocrine effects of limbic activation by electrical, spontaneous, and pharmacological modes: relevance to the pathophysiology of affective dysregulation in psychiatric disorders | Q39168091 |
| | Impact of parent monitoring on initiation of drug use through late childhood | Q39418602 |
| | A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression | Q39420012 |
| | Kindling as a Model for Alcohol Withdrawal Syndromes | Q39738612 |
| | Conditioning and sensitisation in the longitudinal course of affective illness | Q39747714 |
| | Pharmacology of GABA | Q40113222 |
| | Drug abuse and bipolar disorders | Q93633052 |
| | Olanzapine in PDD | Q93900525 |
| | Cocaine, kindling, and psychosis | Q40531092 |
| | The effects of ethanol on striatal dopamine and frontal cortical D-[3H]aspartate efflux oscillate with repeated treatment. Relevance to individual differences in drug responsiveness | Q40932006 |
| | GABA and mood disorders: a brief review and hypothesis | Q40940358 |
| | Incidence and significance of mixed affective states in a bipolar population | Q41060594 |
| | Relative kindling effect of detoxification and non-detoxification admissions in alcoholics | Q41159151 |
| | Multiple withdrawals from chronic ethanol "kindles" inferior collicular seizure activity: evidence for kindling of seizures associated with alcoholism | Q41236326 |
| | Psychiatric diagnosis in cocaine abuse | Q41236482 |
| | Opiates, catecholamines, behavior, and mood | Q41414206 |
| | Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis | Q41434387 |
| | L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders | Q41514582 |
| | The neurobiology of drug addiction | Q41581028 |
| | Clinical application of time-dependent sensitization to antidepressant therapy | Q41734667 |
| | Low plasma GABA is a trait-like marker for bipolar illness | Q42607931 |
| | Convulsive behaviour during alcohol dependence: discrimination between the role of intoxication and withdrawal | Q44185300 |
| | Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients | Q44271596 |
| | The prevalence of psychiatric disorders in patients with alcohol and other drug problems | Q44905612 |
| | Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey | Q44986547 |
| | Increased REM sleep density at admission predicts relapse by three months in primary alcoholics with a lifetime diagnosis of secondary depression | Q46481283 |
| | Kindling in bipolar disorders: a longitudinal follow-up study | Q48225334 |
| | Sensitization and kindling phenomena in mood, anxiety, and obsessive-compulsive disorders: the role of serotonergic mechanisms in illness progression | Q48417423 |
| | Conceptualizing a serotonin trait. A behavioral dimension of constraint | Q48423004 |
| | Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study | Q48561754 |
| | The "switch process" in manic-depressive illness. 3. Theoretical implications | Q48730078 |
| | Recurrence in affective disorder. II. Effect of age and gender. | Q50897597 |
| | Substance abuse and bipolar affective disorder. | Q51133468 |
| | Psychopathology in hospitalized alcoholics. | Q51218977 |
| | Cocaine-induced oscillation is conditionable. | Q51449276 |
| | Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine. | Q51650220 |
| | Psychopathology in drug abusers and their families. | Q51719029 |
| | A comparison of male and female cocaine abusers. | Q51757074 |
| | Psychopathology in chronic cocaine abusers. | Q51815672 |
| | Is death from natural causes still excessive in psychiatric patients? A follow-up of 1593 patients with major affective disorder. | Q52073088 |
| | Psychiatric disorder, drinking and alcoholism: what are the links? | Q52079159 |
| | Relationship of child psychopathology to parental alcoholism and antisocial personality disorder. | Q52212717 |
| | Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. | Q52275733 |
| | Alcohol and drug abuse in patients with affective syndromes. | Q54793999 |
| | Drug Abuse in Schizophrenia and Bipolar Disorder | Q58248834 |
| | Differential Outcome of Pure Manic, Mixed/Cycling, and Pure Depressive Episodes in Patients With Bipolar Illness | Q60447147 |
| | Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid | Q61650044 |
| | Combined valproate and carbamazepine treatment of bipolar disorder | Q68010037 |
| | Pharmacokinetics of valproate and carbamazepine | Q68065728 |
| | Four-year follow-up of twenty-four first-episode manic patients | Q68423068 |
| | Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | Q68610336 |
| | Male primary alcoholics with and without family histories of affective disorder | Q69154203 |
| | Excessive Alcohol Use in Manic-Depressive Illness | Q69728944 |
| | Imipramine treatment of alcoholics with primary depression: A placebo-controlled clinical trial | Q71026605 |
| | Clinical depression in alcoholism | Q71136372 |
| | Attention-deficit hyperactivity disorder and juvenile mania: an overlooked comorbidity? | Q71393232 |
| | A history of substance abuse complicates remission from acute mania in bipolar disorder | Q73235144 |
| | Naltrexone and alcohol dependence. Role of subject compliance | Q73665563 |
| | Twelve-month outcome after a first hospitalization for affective psychosis | Q74066227 |
| | 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode | Q74541226 |
| | A relapse prevention group for patients with bipolar and substance use disorders | Q77793806 |
| P433 | issue | 3 Pt 2 | |
| P921 | main subject | substance P | Q411041 |
| | substance abuse | Q3184856 |
| | bipolar disorder | Q131755 |
| P304 | page(s) | 269-280 | |
| P577 | publication date | 2000-09-01 | |
| P1433 | published in | Bipolar Disorders | Q15716681 |
| P1476 | title | Impact of substance abuse on the course and treatment of bipolar disorder | |
| P478 | volume | 2 | |